• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CRYOLIFE, INC. BIOGLUE SURGICAL ADHESIVE; GLUE, SURGICAL, ARTERIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CRYOLIFE, INC. BIOGLUE SURGICAL ADHESIVE; GLUE, SURGICAL, ARTERIES Back to Search Results
Model Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Meningitis (2389)
Event Type  Injury  
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.
 
Event Description
According to the publication "time to resolution of symptoms after decompression with duraplasty in children with chiari malformation type i" published in world neurosurgery "(2108)" by eveline teresa hidalgo, et al., a retrospective chart review in 105 consecutive children who underwent surgical decompression of symptomatic chiari malformation type i between 1999-2015.Duraplasty was fashioned out of durepair and in some cases distal suture line were reinforced with bioglue.Of the 104 children the complication rate was 3.8% this included 3 cases of clinically significant aseptic meningitis.It was found that in children with prolonged aseptic meningitis bioglue was used in all cases during the initial operation.Fisher exact test showed no significant correlation between the use of bioglue and aseptic meningitis (p= 1.64).
 
Manufacturer Narrative
According to the publication, hidalgo, eveline teresa, et al."time to resolution of symptoms after suboccipital decompression with duraplasty in children with chiari malformation type i." world neurosurgery (2018), the authors performed a retrospective chart review in 105 consecutive children who underwent surgical decompression of symptomatic chiari malformation type 1 between 1999-2015.Duraplasty was fashioned out of durepair and in some cases distal suture line were reinforced with bioglue.Of the 104 children the complication rate was 3.8% this included 3 cases of clinically signification aseptic meningitis, one serratia wound infections.It was found that in children with prolonged aseptic meningitis bioglue was used in all cases during the initial operation.Fisher exact test showed no significant correlation between use of bioglue and aseptic meningitis (p=1.64).The discussion states, ¿although 3 children in our series developed aseptic meningitis that required reoperation, we did not find any statistically significant difference between the type of sealant and the rate of complications.¿ according to an email received from dr.Hidalgo, she reported "as we stated in our publication, we found no association between bioglue and aseptic meningitis.Unfortunately i cannot provide further information." based on the available information, there is insufficient evidence to determine if the aseptic meningitis was caused by bioglue or the duraplasty graft.There is no indication following research to date that aseptic meningitis following suboccipital decompression surgery has been caused by bioglue.Based on the information available at the time of this report, it is not possible to determine a definitive cause of the observed complication.Per the study report, there was a ¿lack of statistical correlation between sealant use and aseptic meningitis¿.Additionally, dr.Hidalgo further confirmed in an email, ¿we found no association between bioglue and aseptic meningitis.¿ this report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to cryolife is accurate or has been confirmed by cryolife.
 
Event Description
According to the publication "time to resolution of symptoms after decompression with duraplasty in children with chiari malformation type i" published in world neurosurgery (2108) by eveline teresa hidalgo, et al., a retrospective chart review in 105 consecutive children who underwent surgical decompression of symptomatic chiari malformation type i between 1999-2015.Duraplasty was fashioned out of durepair and in some cases distal suture line were reinforced with bioglue.Of the 104 children the complication rate was 3.8% this included 3 cases of clinically significant aseptic meningitis.It was found that in children with prolonged aseptic meningitis bioglue was used in all cases during the initial operation.Fisher exact test showed no significant correlation between the use of biglue and aspetic meningitis (p= 1.64).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOGLUE SURGICAL ADHESIVE
Type of Device
GLUE, SURGICAL, ARTERIES
Manufacturer (Section D)
CRYOLIFE, INC.
1655 roberts blvd., nw
kennesaw GA 30144
MDR Report Key7797835
MDR Text Key117613892
Report Number1063481-2018-00034
Device Sequence Number1
Product Code MUQ
Combination Product (y/n)N
PMA/PMN Number
P010003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Type of Report Initial,Followup
Report Date 10/22/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Distributor Facility Aware Date08/07/2018
Initial Date Manufacturer Received 08/07/2018
Initial Date FDA Received08/20/2018
Supplement Dates Manufacturer Received08/07/2018
Supplement Dates FDA Received10/22/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-